Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04722601
Title A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Chicago
Indications

follicular lymphoma

Therapies

Azacitidine + Venetoclax

Azacitidine + Obinutuzumab + Venetoclax

Obinutuzumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.